Bitcoin
77360.11
+2197.02
+2.84%
Crude Oil
83.11
-11.58
-13.93%
Gold
4879.2
+70.9
+1.45%
Copper
6.09
+0.01
+0.2%
Silver
81.5
+2.79
+3.42%
Dow Jones
48578.73
+115
+0.24%
SP500
7125.58
+84.3
+1.18%
NASDAQ
24102.7
+86.68
+0.36%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
9.75
+99.00%
Top Gainers
810,291
Top Gainers
12.3
+98.75%
Top Gainers
749,212
Top Gainers
7530
+90.00%
Top Gainers
250,333
Top Gainers
3980
+90.00%
Top Gainers
360,142
Top Gainers
7200
+80.00%
Top Gainers
253,878
Top Gainers
2695
+80.00%
Top Gainers
144,228
Top Gainers
6.7879
+69.21%
Top Gainers
253,644
Top Gainers
3726
+50.00%
Top Gainers
1,041,976
Top Gainers
10.49
+41.85%
Top Gainers
170,650
Top Gainers
6.2
+35.65%
Top Gainers
182,939
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
293
-1399.25%
Top Loosers
10,908,740
Top Loosers
82700
-104.96%
Top Loosers
763,022
Top Loosers
115.925
-31.37%
Top Loosers
171,950
Top Loosers
1.815
-29.48%
Top Loosers
4,504,352
Top Loosers
558
-21.86%
Top Loosers
344,258
Top Loosers
1.85
-21.08%
Top Loosers
1,018,288
Top Loosers
17.19
-19.14%
Top Loosers
789,254
Top Loosers
1.9
-17.89%
Top Loosers
766,970
Top Loosers
6.18
-16.83%
Top Loosers
1,225,416
Top Loosers
1.91
-16.75%
Top Loosers
785,965
Top Loosers

In Today's Headlines

Alight, Inc. (ALIT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
03:39
18 Apr 2026
Alight, Inc. (ALIT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, April 17, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Alight, Inc. ("Alight" or the "Company") (NYSE: ALIT). IF YOU SUFFERED A LOSS ON YOUR ALIGHT INVESTMENTS, CLICK  HERE BEFORE MAY 15, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
03:37
18 Apr 2026
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

LANGHORNE, Pa., April 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it is moving up its shareholder update conference call from Thursday, April 23rd to Tuesday, April 21st, 2026, at 4:30 P.M. ET.

lululemon: New Styles Are Driving Full-Price Sales
03:36
18 Apr 2026
lululemon: New Styles Are Driving Full-Price Sales

lululemon remains a compelling rebound play after a ~20% YTD decline, with valuation and international growth supporting a buy rating. LULU is reigniting product innovation and seeing robust 20%+ international growth, offsetting stagnant U.S. sales and brand headwinds. Despite margin compression from tariffs and markdowns, LULU maintains mid-50% gross margins and a strong cash position, trading at 13x FY26 P/E.

Bristol-Myers Squibb: The Market Is Not Pricing The Growth Portfolio That Replaces The Patent Cliff
03:35
18 Apr 2026
Bristol-Myers Squibb: The Market Is Not Pricing The Growth Portfolio That Replaces The Patent Cliff

Bristol-Myers Squibb is deeply undervalued at 8.9x forward earnings due to overblown patent cliff fears on Eliquis and Opdivo. The Growth Portfolio now generates 55% of revenue, grew 17% in FY2025, and is guided to continue double-digit growth into 2026. Key catalysts include the August 2026 FDA decision on iberdomide and the upcoming milvexian Phase 3 results, both with multi-billion dollar potential.

Appian: A Positive Setup Ahead Of Earnings, As AI And Federal Deals Jump
03:35
18 Apr 2026
Appian: A Positive Setup Ahead Of Earnings, As AI And Federal Deals Jump

Appian remains a compelling buy amid the SaaSpocalypse, trading near multi-year lows despite strong execution and AI-driven tailwinds. AI adoption is boosting APPN's workflow demand and subscription pricing, with improved retention rates supporting the core automation thesis. Federal sector expansion, enabled by FedRAMP certification, is driving significant growth and diversifying APPN's revenue streams.

Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
03:32
18 Apr 2026
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa., April 17, 2026 /PRNewswire/ -- The Law Offices of Howard G.

Amazon's stock peeks into record territory, as the AI script has flipped to a positive
03:32
18 Apr 2026
Amazon's stock peeks into record territory, as the AI script has flipped to a positive

Shares of Amazon moved briefly into record territory on Friday, just a few months after fears over the tech giant's massive planned spending on artificial intelligence triggered a major selloff.

Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell Carcinoma Transcript
03:31
18 Apr 2026
Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell Carcinoma Transcript

Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell Carcinoma Transcript

Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
03:31
18 Apr 2026
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa., April 17, 2026 /PRNewswire/ -- The Law Offices of Howard G.

Oracle and Other Beaten-Down Tech Stocks Surge in Latest Market Rally
03:30
18 Apr 2026
Oracle and Other Beaten-Down Tech Stocks Surge in Latest Market Rally

This week has seen some big tech winners. Many of them were big losers not too long ago.